Order Article Reprints

Richert I, Berchard P, Abbes L, Novikov A, Chettab K, Vandermoeten A, Dumontet C, Karanian M, Kerzerho J, Caroff M, et al. A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages. Cancers. 2023; 15(18):4635. https://doi.org/10.3390/cancers15184635

Richert, Iseulys, Paul Berchard, Lhorra Abbes, Alexey Novikov, Kamel Chettab, Alexandra Vandermoeten, Charles Dumontet, Marie Karanian, Jerome Kerzerho, Martine Caroff, and et al. 2023. "A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages" Cancers 15, no. 18: 4635. https://doi.org/10.3390/cancers15184635

Richert, I., Berchard, P., Abbes, L., Novikov, A., Chettab, K., Vandermoeten, A., Dumontet, C., Karanian, M., Kerzerho, J., Caroff, M., Blay, J.-Y., & Dutour, A. (2023). A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages. Cancers, 15(18), 4635. https://doi.org/10.3390/cancers15184635